Evidence map›Paper›PMID 29764953›Full record

ArticlemBio2018

Fighting Antibiotic-Resistant Klebsiella pneumoniae with "Sweet" Immune Targets.

Roberto Adamo, Immaculada Margarit

Open access · goldAbstract readComment
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Materials today. Bio · 2026
    Article
  2. Co-evolution of resistance and virulence inFrontiers in cellular and infection microbiology · 2026
    Review
  3. Identification of plasmid encodedIranian journal of microbiology · 2025
    Article
  4. Review
  5. Nanomaterials for Delivering Antibiotics in the Therapy of Pneumonia.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Article
  8. Article
  9. Silver Nanoparticles Induce aFrontiers in microbiology · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Targeting the Sugary Armor ofFrontiers in cellular and infection microbiology · 2019
    Review
  14. Intradermal Immunization with Heat-KilledInternational journal of applied & basic medical research
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Roberto AdamoGSK, Siena, Italy.
Immaculada MargaritGSK, Siena, Italy immaculada.x.margarit-y-ros@gsk.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotics and vaccines have greatly impacted human health in the last century by dramatically reducing the morbidity and mortality associated with infectious diseases. The recent challenge posed by the emergence of multidrug-resistant bacteria could possibly be addressed by novel immune prophylactic and therapeutic approaches. Among the newly threatening pathogens,

Indexed as

Anti-Bacterial AgentsKlebsiella pneumoniaeAnimalsAntibodies, MonoclonalCandyCarbapenemsHumansKlebsiella InfectionsMiceAnti-Bacterial AgentsAntibodies, MonoclonalCarbapenemsantimicrobial resistancecapsular polysaccharideimmune therapyKlebsiella pneumoniaevaccines

Identifiers

PMID29764953
PMCPMC5954227
OpenAlexW2804279095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.